Zimmer Biomet stock holds near $98 after strong quarter

Published on 09/06/2026 at 12:20 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Zimmer Biomet stock held near USD 98 after a quarter with USD 2.18 billion in revenue and adjusted EPS of USD 2.07.

Titan-Knieimplantat auf Edelstahltisch in steriler Medizintechnik-Fertigung — Zimmer Biomet US98956P1021 zeigt Titan-Knieimplantat mit orthopädischen Instrumenten in steriler Fertigungsumgebung nahaufnahme, Illustration mit AI erstellt.

Zimmer Biomet stock (US98956P1021) traded near USD 98 after the latest market update on September 4, 2026, while the company reported adjusted EPS of USD 2.07 on August 5, 2026 and revenue of USD 2.18 billion. The share price snapshot in the market update showed USD 97.94, down 0.99 percent, with market capitalization at about USD 18.7 billion.

Quarterly numbers set the tone

According to a MarketBeat report, Zimmer Biomet topped the analyst consensus of USD 2.01 EPS by USD 0.06 and revenue also came in above the USD 2.13 billion estimate. Revenue rose 4.8 percent year over year, and the company kept fiscal 2026 EPS guidance at USD 8.47 to USD 8.59.

Hold view and valuation

The same source said the stock traded at a price-to-earnings ratio of 23.83 and a price-to-earnings-growth ratio of 1.87. On the market-cap side, CompaniesMarketCap put Zimmer Biomet at USD 18.70 billion on September 5, 2026, while the MarketBeat quote page showed a close of USD 97.94.

Go deeper

Why Zimmer Biomet matters after August 5

The latest quarter gave investors three clear markers: USD 2.07 EPS, USD 2.18 billion revenue and 4.8 percent growth year over year.

Zimmer Biomet coverage

Orthopedic portfolio

Zimmer Biomet's product range spans hips, knees, shoulders, trauma and dental systems, and the company's Trabecular Metal Technology page highlights more than 20 years of clinical use in orthopaedic applications. That portfolio remains the core driver behind the quarter's revenue base and the current guidance range.

Stock stays near USD 98

Zimmer Biomet stock closed at USD 97.94 on September 4, 2026, and CompaniesMarketCap put market capitalization at USD 18.70 billion on September 5, 2026.